Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cantor Fitzgerald
McKesson
Fish and Richardson
Daiichi Sankyo
Chubb
Covington
Cipla
Queensland Health

Generated: July 23, 2018

DrugPatentWatch Database Preview

Prednisolone acetate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for prednisolone acetate and what is the scope of prednisolone acetate patent protection?

Prednisolone acetate
is the generic ingredient in eighteen branded drugs marketed by Schering, Akorn, Bel Mar, Cent Pharms, Watson Labs, Pfizer, Alcon, Novartis Pharms Corp, Allergan, Taro, Pharmafair, Novartis, and Bausch And Lomb, and is included in twenty-seven NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Prednisolone acetate has thirty-three patent family members in fourteen countries.

There are eighty-seven drug master file entries for prednisolone acetate. Eleven suppliers are listed for this compound.
Pharmacology for prednisolone acetate
Synonyms for prednisolone acetate
(11beta)-11,17-dihydroxy-3,20-dioxopregna-1,4-dien-21-yl acetate
[2-[(8S,9S,10R,11S,13S,14S,17R)-10,13-dimethyl-11,17-bis(oxidanyl)-3-oxidanylidene-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxidanylidene-ethyl] ethanoate
[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
037P710
11b,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-acetate
11beta,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-acetate
2-((1S,10S,11S,15S,17S,2R,14R)-14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8 .7.0.0<2,7>.0<11,15>]heptadeca-3,6-dien-14-yl)-2-oxoethyl acetate
2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate
2-[(1S,2R,10S,11S,14R,15S,17S)-14,17-DIHYDROXY-2,15-DIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-14-YL]-2-OXOETHYL ACETATE
21-Acetoxy-1,4-pregnadiene-11beta,17alpha-diol-3,20-dione
4-08-00-03468 (Beilstein Handbook Reference)
52-21-1
8B2807733D
A828982
AB00443788_13
AB00443788-11
AB2000666
AC-2176
AC1L1L8T
acetic acid [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] ester
AKOS007930677
AKOS015960469
AN-14231
AS-11673
BC201735
Bio-0646
Blephamide Liquifilm
Blephamide S.O.P.
BRN 3111798
C08180
CAS-52-21-1
Cetapred Ointment
CHEBI:8380
CHEMBL1152
component of Composone
component of Isopto Cetapred
component of Metimyd
component of Neo-Delta-Cortef
Cormalone
Cortipred
CS-4642
D00980
Delcort-E
Deltilen
DSSTox_CID_3502
DSSTox_GSID_23502
DSSTox_RID_77056
DTXSID3023502
Durapred
Econopred
Econopred (TN)
EINECS 200-134-1
HMS2234F18
HMS3259O07
HY-B1214
hydroprednisone acetate
LRJOMUJRLNCICJ-JZYPGELDSA-N
LS-118501
Meticortelone acetate
Meticotelone acetate
MFCD00037710
MLS000028512
MLS001148097
MLS002207146
MLS002548870
MolPort-002-507-143
NC00470
NCGC00021925-03
NCGC00094765-01
Nisolone
NSC 10966
NSC-10966
NSC10966
Omnipred
Opera_ID_332
P1283
PL008096
Pred Forte
Pred forte (TN)
Pred Forte TM 1%
Pred Mild
Pred-G Liquifilm
Pred-G S.O.P
Pred-G S.O.P.
Predalone 50
Prediacortine
Predicort
Prednelan-N
Prednidoren
Prednisolone (21-acetate)
Prednisolone 21-acetate
Prednisolone 21-acetate, >=97%
Prednisolone 21-acetate, VETRANAL(TM), analytical standard
Prednisolone acetate (JP17/USP/INN)
Prednisolone acetate (Omnipred)
Prednisolone acetate [BAN:JAN]
Prednisolone acetate [USP:JAN]
Prednisolone acetate for peak identification, European Pharmacopoeia (EP) Reference Standard
Prednisolone acetate, European Pharmacopoeia (EP) Reference Standard
Prednisolone Acetate, pharmaceutical secondary standard, traceable to USP, PhEur, BP
Prednisolone acetate, United States Pharmacopeia (USP) Reference Standard
PREDNISOLONE-21-ACETATE
Predonine injection
Pregna-1,20-dione, 11.beta.,17,21-trihydroxy-, 21-acetate
Pregna-1,20-dione, 21-(acetyloxy)-11,17-dihydroxy-, (11.beta.)-
Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-, 21-acetate
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-, 21-acetate
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-, 21-acetate (8CI)
Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-, (11b)-
Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-, (11beta)-
Prenema
Pricortin
Q-201614
s2570
SCHEMBL7999
SMR000058326
ST075202
Sterane IM and IA
Supercortyl
Tox21_111328
Tox21_111328_1
UNII-8B2807733D
Vasocidin Ointment
ZINC3875348

US Patents and Regulatory Information for prednisolone acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn PREDAMIDE prednisolone acetate; sulfacetamide sodium SUSPENSION/DROPS;OPHTHALMIC 088059-001 Jul 29, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pfizer STERANE prednisolone acetate INJECTABLE;INJECTION 011446-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alcon CETAPRED prednisolone acetate; sulfacetamide sodium OINTMENT;OPHTHALMIC 087771-001 Aug 6, 1993 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmafair PREDSULFAIR II prednisolone acetate; sulfacetamide sodium SUSPENSION/DROPS;OPHTHALMIC 088837-001 Dec 24, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for prednisolone acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-002 Jan 17, 2008 ➤ Sign Up ➤ Sign Up
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-002 Jan 17, 2008 ➤ Sign Up ➤ Sign Up
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-001 Jan 17, 2008 ➤ Sign Up ➤ Sign Up
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-002 Jan 17, 2008 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for prednisolone acetate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,206,727 Oral suspension of prednisolone acetate ➤ Sign Up
8,461,139 Oral suspension of prednisolone acetate ➤ Sign Up
6,355,258 Method for formulating spill resistant pharmaceutical compositions in semi-solid form ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
AstraZeneca
Medtronic
Cantor Fitzgerald
Cerilliant
McKesson
Moodys
Farmers Insurance
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.